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ABSTRACT In order to expedite the rapid and efficient discovery and isolation of novel 
specialized metabolites, whilst minimizing the waste of resources on rediscovery of known 
compounds, it is crucial to develop efficient approaches for strain prioritization, rapid 
dereplication, and the assessment of favored cultivation and extraction conditions. Herein we 
interrogated bacterial strains by systematically evaluating cultivation and extraction parameters 
with LC-MS/MS analysis and subsequent dereplication through the Global Natural Product 
Social Molecular Networking (GNPS) platform. The developed method is fast, requiring 
minimal time and sample material, and is compatible with high throughput extract analysis, 
thereby streamlining strain prioritization and evaluation of culturing parameters. With this 
approach, we analyzed 146 marine Salinispora and Streptomyces strains that were grown and 
extracted using multiple different protocols. In total, 603 samples were analyzed, generating 
approximately 1.8 million mass spectra. We constructed a comprehensive molecular network and 
identified 15 molecular families of diverse natural products and their analogues. The size and 
breadth of this network shows trends in the molecular diversity when comparing growth and 
extraction conditions, supported by statistical analyses. This network provides an extensive 
survey of the biosynthetic capacity of this strain collection and a method to compare strains 
based on the variety and novelty of their metabolites. This approach allows us to quickly identify 
patterns in metabolite production that can be linked to taxonomy, culture conditions, and 
extraction methods, as well as informing the most valuable growth and extraction conditions.   
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Nearly half of all small molecules drugs approved for use in humans are derived from natural 
products.1 The ability to sequence bacterial genomes at constantly decreasing costs and time has 
dramatically changed the field of natural products discovery research over the past decade. With 
a growing number of genomes sequenced, comparative genomics and novel bioinformatics 
approaches have been used to analyze and classify biosynthetic gene clusters (BGCs) on a larger 
scale.2 It has been commonly observed that many organisms contain far more BGCs than 
characterized natural products. One approach to overcome this gap and further characterize 
natural product diversity is to culture and extract the microbes in many different ways. This 
approach has been developed and named OSMAC (one strain, many compounds) by Zeeck and 
co-workers.3 It was first employed in the early 2000s and has led to the isolation of large 
numbers of novel metabolites by systematically altering cultivation parameters.4  
Natural products chemists frequently face the challenge of rediscovery of known compounds. 
Several mass-spectrometry-based metabolomics workflows have been developed to ameliorate 
this high rediscovery rate, referred to as “dereplication”.5 However, many of these approaches 
solely use MS1 data, thus identifying compounds only by mass, and chromatographic and 
spectroscopic properties, and are not able to determine structural relationships between the 
metabolites.  
Molecular networking is a recently introduced concept for the analysis of mass spectrometric 
fragmentation data and assessment of structural similarities between measured metabolites. The 
molecular networking concept enables the visualization of large datasets and the grouping of the 
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fragmented ions into clusters, using an algorithm to compare the similarity of the fragmentation 
spectra.6 In a molecular network of natural product samples, these clusters represent molecular 
families (MF) putatively synthesized by gene cluster families (GCF).7 Molecular networking is a 
powerful approach that has advanced several natural product-related research projects involving 
dereplication and quantification,8 discovery,9 biosynthesis,10 and chemical ecology.11 It has also 
been integrated as a central component of the Global Natural Products Social (GNPS) molecular 
networking platform, where dereplication is performed against a large, community-acquired 
reference library of spectra.12 Molecular networking further allows for the screening of large 
numbers of strains for metabolic assessment.7 
Creating networks with large numbers of closely related strains provides opportunities to identify 
new molecular families and investigate differences when growth and extraction conditions are 
changed. In this study, we screened 146 marine Salinispora and Streptomyces strains using 
HPLC-MS/MS, molecular networking, and the GNPS platform. We aimed to systematically 
explore the culturing and extraction of these strains to gain insight into the distribution of known 
and unknown metabolites and the effects of different growth and extraction protocols on the 
compounds detected. Analysis of the networks showed that varying conditions such as culture 
medium, extraction solvent, and time impact the networks. Furthermore, this study highlights 
species- and genus-specific metabolite production on a larger scale and allows for the 
prioritization of strains and optimized conditions for future MS-guided natural product discovery 
projects.  
RESULTS AND DISCUSSION 
Cultivation, Extraction and Generation of Molecular Networks. The objective of this 
study was to apply large-scale molecular networking to a closely related group of sequenced 
 5 
bacteria to comprehensively interrogate the effects of growth media and extraction methods on 
the production and recovery of specialized metabolites respectively and to prioritize strains that 
produce novel molecular families for further study. We selected marine actinomycete bacteria, as 
they are known to be prolific producers of secondary metabolites.13 First, we established an 
effective small-scale extraction method for the HPLC-MS/MS-based screening and analysis. 
Extraction was carried out sequentially with three solvents (EtOAc, n-butanol and MeOH) of 
increasing polarity. To evaluate the relationships between bacterial species and chemical 
diversity, 120 Salinispora strains were cultivated on A1 agar (Table S1). The obligate marine 
actinomycete genus Salinispora consists of three named species, arenicola, pacifica and 
tropica,14 that are phylogenetically closely related15 and produce a wide range of bioactive 
secondary metabolites.16 Recent studies have shown that certain secondary metabolites are 
consistently produced by individual species,15, 17 which has been supported at the genomic level 
based on BGC distributions.2c, 18 We additionally selected 26 marine Streptomyces strains and, in 
order to evaluate the effects of media composition on metabolite production, we grew them on 
three different media, A1, MS and R5 agar (Table S1). Complete genomes are available for all 
selected strains to facilitate future research programs. In total, 603 samples were analyzed, 
generating approximately 1.8 million mass spectra that were processed with the GNPS molecular 
networking workflow.12 
The final network was generated for spectra with a minimum of four fragment ions and by 
merging all identical spectra (generating individual nodes). Only nodes that had at least two 
identical spectra were displayed. After removal of solvent blanks, the molecular network 
consisted of 5526 nodes connected with 7396 edges. 54.6% of the nodes were organized into a 
total of 472 molecular families, comprised of two or more nodes each. The remainder of the 
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MS/MS spectra are sufficiently unique that they did not form any connections to other spectra. 
Additionally, previously published data from 35 Salinispora strains19 grown in liquid culture 
were incorporated from the publically available GNPS-MassIVE database,12 allowing for 
comparisons between liquid and solid cultivation conditions. For comparisons between growth 
media, only the samples obtained from Streptomyces were networked with each other (Figure 
S1). It is important to note that the number of nodes in the network does not correspond exactly 
to the number of metabolites, as can be seen for different adducts or different charge states of the 
same chemical species. Rather, molecular networking provides an overview of the different 
chemistries detected by mass spectrometry.  
              Analysis of Known Molecular Families in the Molecular Network. We identified 15 
molecular families that contained spectra that matched known compounds in the network based 
on the curated GNPS natural products library (Figure 1, Table S2). In our analysis, we applied a 
mass exclusion threshold of 400 Da to limit our detection to large metabolites. In doing so we 
excluded well-known Salinispora molecules such as the saliniketals and salinisporamides, 
although we did identify some small molecules that formed oligomers in the gas phase, such as 
ammosamide B ([3M+Na]+: 896.14 Da). Several of these known compounds, such as the 
enterocins,20 were identified in strains that were not previously known as producers. A large 
number of putative new analogues of known compounds were also identified in the network. For 
example there are three analogues of salinamide which do not correspond to any library variants, 
one of which, based on the parent mass, likely corresponds to salinamide F.21  
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Figure 1 Molecular Network of all Generated Extracts. Blue nodes represent ions extracted 
only from Streptomyces, red nodes ions detected only from Salinispora strains grown on agar. 
The yellow nodes represent ions detected from Salinispora only in liquid medium,19 while the 
orange nodes represent ions detected both in liquid and solid media. Purple nodes represent ions 
detected in both Streptomyces and Salinispora. Molecular families that include standards from 
the GNPS library are highlighted in the network (displaying the structure of the most abundant 
analogue) and color-coded according to their source. GNPS IDs of the standards can be found in 
Table S2. Only clusters containing at least two nodes are shown.  
 
Four molecular families were produced by both Salinispora and Streptomyces. The 
desferrioxamine family, a group of hydroxamate siderophores,22 includes over 50 congeners, 
including acylated derivatives have only been detected from Streptomyces strains before.11b, 23  
The staurosporine molecular family24 consists of a total of 11 members, mainly produced by 
Salinispora strains, but hydroxystaurosporine was also found in Streptomyces CNQ-149. This 
molecular family is produced by a large portion of the Salinispora strains - staurosporine was 
detected from a total of 61 strains, 56 S. arenicola and 5 S. pacifica, while the gene cluster is 
present in all 62 S. arenicola and 16 S. pacifica strains. 25 The rifamycin molecular family 
consists of 25 members mostly detected in Salinispora arenicola strains;26 however, rifamycin 
W was also produced by one Streptomyces strain. The rosamicin family, a group of glycosylated 
polyketides, is produced by five Salinispora strains and one Streptomyces strain. Having initially 
detected this family in this dataset, we recently isolated and characterized three novel rosamicins, 
and their biosynthetic byproducts salinipyrones and pacificanones from S. pacifica CNS-237.27  
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          Analysis of Network by Genus and Species and PCoA Visualization of the Overall 
Chemical Diversity. Despite belonging to different families within the Actinomycetales, there 
was considerable overlap (16.4%) in the compounds detected in the Salinispora and 
Streptomyces extracts (Figures 2A, S2). Those shared between the two genera include lipids but 
also natural products, including the desferrioxamines and the rosamicins, as described above. 
Salinispora and Streptomyces extracts in general have similar molecular diversities, averaging 
10.4 and 11.5 different nodes per sample, respectively. However, the larger number of 
Salinispora extracts examined accounts for the relatively high percentage of the total (51.3%) 
that is specific to this genus. Within the closely related and well-defined Salinispora strains, it is 
possible to analyze the distribution of extracted metabolites by species (Figures 2B, S3). As 
described above, Salinispora is known to produce species-specific metabolites.17 In this work, 
the production of known molecules follows a similar pattern as in previous studies showing 
rifamycins as a strong marker for S. arenicola, while lomaiviticins are only produced by the taxa 
S. pacifica and S. tropica. Staurosporines are produced by S. arenicola and S. pacifica, while 
desferrioxamines are produced by all three species (Table S2). The wide distribution of 
desferrioxamines and staurosporines is reflected in the corresponding gene cluster patterns, 
where, of the 120 strains, 92 and 78, respectively, possess these gene clusters.  
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Figure 2 Effects of Genus and Species on Molecular Diversity-Network Analysis. A. Venn 
diagram for Salinispora and Streptomyces specific nodes in the networks. B. Venn diagram 
displaying Salinispora species node distribution. C. PCoA plots of Salinispora (blue) and 
Streptomyces (red) samples separated using Gower (left) and random forest classifier (right). D. 
Salinispora samples were reanalyzed with unsupervised (left) and supervised (right) random 
forest based on Salinispora species. 
When the whole Salinispora network is analyzed for metabolite production by species, it is 
apparent that more than half of the total nodes (57.6%) were found in only one of the three 
species. This observation clearly shows that that there can be great differences in secondary 
metabolism even among very closely related species.  
In addition, network consensus nodes in each sample were subjected to multivariate analyses. 
Intra-sample distances were determined using both the Gower distance metric, as well as the 
random forest classifier, and visualized using PCoA dimensional reduction. The PCoA analysis 
showed that Salinispora and Streptomyces samples occupy mutually exclusive areas of this 
chemical space outside of a shared core (Figure 2C). Since the unsupervised Gower PCoA 
analysis (Figure 2C, left) did not show a clear grouping pattern between most metadata labels, 
we turned to the random forest classifier (Figure 2C, right).28 With the PCoA approach, one can 
use the random forest algorithm’s ability to classify samples into specified (supervised) or 
unspecified (unsupervised) groups as the basis of a dissimilarity metric retrieved from proximity 
matrices.29 We applied this technique to the 360 Salinispora-derived samples, classifying on the 
basis of species (Figure 2D). The random forest classifier was able to differentiate the 
Salinispora species with an accuracy of 87%, showing that the metabolic information captured 
by mass spectrometry provides a consistent fingerprint of each species. Interestingly, the top 
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drivers for this species-specific PCoA separation were analogs of the previously discussed 
bioactive alkaloid staurosporine, while the influence of media components for this analysis could 
be excluded (Figure S4). The PCoA analysis thus supports the observations from the molecular 
network and helps in building a global and comprehensive metabolic picture for the genus 
Salinispora. 
 
     Impact of Additional Attributes on the Network  
Strain: For the prioritization of strains for further isolation studies, a direct comparison of their 
metabolic profiles is beneficial. Within the network, each strain contributes to a certain number 
of nodes, thus giving a direct measure of extracted molecular diversity. Because the strains from 
each genus were grown and extracted under the same conditions, it was possible to compare 
them in the network. One example of a chemically rich strain is Streptomyces sp. CNQ-329 that 
contributes to 451 nodes in the network (Table S1). This number can be further broken down 
into nodes by medium, revealing that R5 medium gives the most diversity with 339 nodes alone. 
Looking at extraction solvents, from the R5 samples, MeOH and butanol (BuOH) provide the 
most chemical diversity, with 269 and 252 nodes per sample respectively. From the Salinispora 
strains, S. arenicola CNY-231 yielded the highest chemical diversity contributing to 279 nodes 
in total. In this case, each solvent extracts a similar amount of molecular diversity (194, 179 and 
208 nodes from BuOH, EtOAc and MeOH, respectively). It is important to note that the 
individual Salinispora strains were grown on just one medium, giving rise to the smaller total 
number of nodes compared to Streptomyces strains. Conversely, some strains yielded very little 
chemical diversity, with the approach used. Salinispora pacifica CNY-703, for example, 
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contributed to only six nodes in the network. These results help in prioritizing strains with higher 
chemical diversity and also in defining the culture and extraction conditions that give the highest 
yields of target metabolites. 
Solvent and Medium: When the network was sorted for extracted ions by solvent, a comparable 
number of nodes were extracted by each of the three solvents (Figures 3A, B, S5). This can be 
visualized with an accumulation curve of the number of unique clusters added by each additional 
sample, incorporating all of those extracted with EtOAc, before adding those from BuOH and 
then MeOH, reflecting the order they were used in the extraction (Figure 3A). The inflection 
upon addition of spectra from samples extracted with a new solvent indicates an influx of new 
clusters. A Venn diagram of the nodes originating from each solvent shows that almost half 
(42%) of the nodes were extracted by just one solvent and, of the three solvents, MeOH yielded 
the highest number of unique nodes (Figure 3B). A total of 57 molecular families were extracted 
by a single solvent (EtOAc x12, BuOH x20, and MeOH x25), which would have been missed in 
the network by the exclusion of any of these solvents. Several of the known compounds were 
only extracted by one solvent, including salinamide E (BuOH), antimycin A1 (MeOH), and 
arenimycin A (EtOAc). Three analogues of the lomaiviticin family, including lomaiviticin A, 
were extracted by only EtOAc, and two compounds of the cyclomarin family by MeOH only. 
When random forest dissimilarities are visualized in PCoA space, the distinctions caused by 
solvent differences spread samples in distinct directions (Figure 3C). The three solvents are 
likely able to capture a common core metabolome, but also allow for capturing solvent-specific 
metabolites. These results clearly demonstrate that using three extraction solvents, instead of 
one, greatly enhances the molecular diversity that can be detected by mass spectrometry.  
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To gain insight into medium-dependent metabolomics, all Streptomyces strains were grown on 
three different media (A1, MS and R5). Extracts from these cultures were networked together 
and then analyzed for extracted nodes by culture medium (Figures 3D,E, S1). In this case, the 
generated accumulation curve shows a similar trend as with the solvent extraction analysis, 
showing a rapid increase in molecular diversity with each change of medium (Figure 3D). 
Analysis of nodes in the network by medium reveals that over 70% of the nodes were extracted 
from just one of the three media (Figure 3E).  
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Figure 3 Effects of Additional Attributes on Molecular Diversity-Network Analysis. 
Cumulative consensus curves for added unique spectra by each additional solvent (A) and Venn 
diagram for node distributions in the network for each solvent (B). C. Supervised random forest 
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analysis of all samples classified by solvent. Cumulative consensus curves (D) and Venn 
diagram (E) for each medium (only from the Streptomyces extracts). Percentages are shown for 
each sector, with the total percentage for each treatment in parentheses. F. Supervised random 
forest analysis of all samples classified by growth medium. G. Comparison of liquid and solid 
extraction for 30 Salinispora strains (solvent: EtOAc). 
 
This observation corroborates observations from the OSMAC method,3 that culture medium is a 
key factor in secondary metabolite biosynthesis. We identified a total of 89 clusters in the 
Streptomyces network that were produced on just one medium (35 on A1, 29 on MS, and 25 on 
R5), including some of the detected standards. As we only evaluated metabolites with a 
molecular weight over 400 Da in this analysis, we do not anticipate inclusion of by-products of 
core metabolism. To provide some examples, most of the rosamicin molecular family was only 
produced on A1, which was also necessary for production of five of the seven known 
salinamides, including salinamides A and E. Additionally, many of the detected desferrioxamine 
family analogues were only produced on R5 media, as were the entire alteramide and antimycin 
molecular families. All samples were classified with supervised random forest by the media 
information (Figure 3F) and differences are clearly seen to spread samples in distinct directions 
in the PCoA space. Thus, this analysis rapidly visualizes how much the metabolic repertoire is 
dependent on medium composition.   
Solid Versus Liquid Media: Previously, 35 Salinispora strains were grown in liquid A1 medium, 
extracted and analyzed in a similar way to this project.19 When the comparable data from this 
previous work is networked with the same 30 sequenced strains from solid A1 media, we 
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observed less than 7% overlap of extracted metabolites (Figures 3G, S6). Interestingly, most of 
the metabolic overlap belongs to known molecular families that could be dereplicated by 
comparison to standards in the GNPS database. The cyclomarins are represented in two adducts 
in the network, the sodiated form and the dehydrated and protonated form (Figure 1). These 
adducts display significantly different fragmentation patterns, and thus they form two distinct 
molecular families. Analysis of both molecular families shows that only cyclomarin A was 
extracted from both solid and liquid media. We observed that some cyclomarin analogues were 
extracted from only the liquid or the solid media growths, thereby clearly demonstrating the 
culture-dependent variability in production of compounds of the same class. In the case of the 
arenicolide molecules, we detected only an unprecedented hydrated analogue of arenicolide A 
from the solid growth medium (Figure S7), while six arenicolide analogues were produced in 
liquid medium.   
Taken together, the comparison between growth on solid and liquid medium for 30 Salinispora 
strains shows production of almost entirely different chemistry. The observed metabolic 
differences of liquid versus solid media suggest that a network with liquid culturing data of all 
146 strains would look significantly different and may help to capture a broader map of the 
metabolic potential of these bacteria. 
Location: The network was also queried for molecular families produced by several strains from 
one collection location or locations relatively close to each other (Figure S8). One example is a 
molecular cluster found to be extracted by two strains collected from Guam, Salinispora pacifica 
CNQ-768 and Streptomyces sp. CNQ-865 with a parent mass of m/z 878.152. This observation 
implies that the corresponding gene cluster, which we have been unable to identify, is uniquely 
shared between these two geographically related strains. Although other strains may also have 
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the cluster, it was apparently not expressed under these experimental conditions. A second 
cluster, consisting of 16 nodes, is evident from ten strains of S. pacifica and S. arenicola isolated 
from expeditions to Hawaii and Fiji in the central Pacific. A third cluster, consisting of four 
nodes, is produced by four Fijian S. pacifica strains. One of the largest molecular families 
consisted of 152 nodes in which 137 were extracted from strains collected from Hawaii. The 
remaining 15 nodes were derived from Salinispora and Streptomyces strains isolated from the 
Pacific (Fiji, Guam, Palmyra, San Diego, Channel Islands and the Sea of Cortez). Thus, the 
analysis implies that the biosynthetic genes responsible for these various metabolites are locally 
restricted to strains in our collection isolated from the Pacific Ocean.  
Culture Time: Another dimension that can be added to the variation of conditions is the length 
of culturing before extraction. This is particularly valuable for experiments seeking to determine 
the best time point for preparative isolation of molecules, or to observe formation and changes of 
compound patterns over time.6b To gain insight into temporal natural product changes, we grew 
S. arenicola CNH-877 in four different liquid media and extracted at three different time points: 
14, 21 and 28 days post inoculation (Figure S9). We observed that the number of produced and 
extracted ions steadily increased over time (Figure 4A), and that after 28 days, there is far higher 
molecular diversity than at 14 or 21 days. The temporal changes in metabolite production and 
distribution can be exemplified with the staurosporine molecular family group (Figure 4B, Table 
S3).24 The staurosporine (STA) molecular family in the ISP2 network consists of 11 nodes, eight 
of which can be connected to known STA analogues by exact mass. Analysis of the nodes 
reveals a steady number of spectral counts for STA and oxo-STA across the different samples, 
while there is an increase in spectra corresponding to hydroxy-STA, methyl-STA and methyl-
hydroxy-STA. Dihydroxy-STA was detected after 21 days and with an increase in spectral 
 19 
counts in the last time point. The production of minor analogues, whose masses were previously 
reported from a Saccharothrix strain, was only detected after 28 days.30 These results illustrate 
the biosynthetic changes and intramolecular conversions of a family of related molecules over 
time.6b, 31 
 
Figure 4 Time-dependent Changes in Natural Product Distribution in Salinispora arenicola 
CNH-877, Grown in ISP2. A shows a Venn diagram representing node distributions in the 
molecular network at three time points (14, 21 and 28 days). B shows the staurosporine (STA) 
molecular family in the network. Nodes represent masses (m/z) and edge thickness corresponds 
to cosine score between the nodes. Highlighted in red are masses that are present in samples 
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taken at 14, 21 and 28 days. Orange nodes represent masses only present after 21 and 28 days, 
violet nodes are only present after 28 days. 
CONCLUSIONS 
Natural products discovery and structure elucidation is a time consuming and sometimes 
inefficient process fraught with the rediscovery of known compounds. To advance natural 
product research, it is thus crucial to develop rational and effective strategies for the discovery of 
novel natural products entities and scaffolds. Emerging concepts like genome mining and MS-
guided metabolomics have accelerated this process in recent years. We believe that one efficient 
strategy in a rational, state-of-the-art drug discovery program is the quick assessment of the 
metabolic capacities of natural product producers under various lab conditions, coupled with 
correlation of genomic and metabolic data for accelerated discovery and dereplication processes. 
In this study, we generated a comprehensive picture of the molecular diversity from 146 
actinomycete strains from the marine environment. The selection of strains with sequenced 
genomes will help in the utilization of this data in future studies. To achieve maximal molecular 
diversity in an efficient manner, we developed a simple culturing and extraction protocol and 
evaluated the variable factors that influence metabolite identification.  
In previous studies on the molecular diversity of Salinispora, much smaller numbers of strains 
were grown on just one medium and extracted under just one condition.19, 32 Thus, the data in this 
study, generated from 120 Salinispora strains with three extraction solvents, and the 
visualization in a molecular network give a more comprehensive and detailed picture of the 
Salinispora metabolome. The species-specific production of many known and unknown 
metabolites is well reflected in the network and clearly visualized by supervised random forest 
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analysis. To produce an even larger picture with two “talented” genera, 26 Streptomyces strains 
were grown and extracted in the same way as the Salinispora strains, but on three media instead 
of one. In total, 15 structurally diverse molecular families could be annotated as known 
compound classes in the network, including numerous as yet undescribed congeners. The size of 
the network and diversity of included samples allowed us to observe clear trends in comparing 
attributes, such as growth and extraction conditions, at the level of molecular diversity, supported 
by statistical analyses. It also allowed us to quickly compare strains and prioritize chemically 
rich isolates for more detailed profiling, as well as informing the most valuable growth and 
extraction conditions.  
In light of the OSMAC approach, the changes of the metabolomes can be rationalized, as the 
different media represent different environments that the bacteria are exposed to, requiring them 
to alter their behavior. The culturing in liquid versus solid media, comparable to environments on 
surfaces versus the open water, greatly influences not only the development of the bacteria, but 
also the production of specialized metabolites. To our knowledge, there has not been a 
systematic investigation of the effect of culturing and extraction parameters on a larger number 
of strains with mass spectrometric tools.33 Here, the expanded molecular diversity that is added 
to the network by each additional treatment (medium, agar, solvent) shows clearly, how much 
molecular diversity can be missed when just one medium, solvent, or time point is used to assess 
the metabolic capacity. Parameters like time of extraction and solvent are of great importance for 
the extracted metabolite spectrum and should always be kept in mind when creating a natural 
products isolation workflow. With molecular networking, optimization of culturing and 
extraction parameters can now be assessed quickly and implemented early into the discovery 
workflow. The results of this study encourage further applications of the OSMAC approach by 
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natural product chemists and this workflow can be applied to microbes across all three domains 
of life (Eukaryotes, Prokaryotes, and Archaea). To conclude, this network provides an extensive 
survey of the biosynthetic capacity of this strain collection and, with the GNPS database 
continuing to expand, this will provide a living dataset to inform future rational and automated 
natural product discovery efforts in the genera Salinispora and Streptomyces. 
 
EXPERIMENTAL SECTION 
Culturing and Extraction. Salinispora strains were cultured on A1 agar (6-well plates). 
10 mg/ml phenol red was added to the medium to indicate the beginning of stationary phase 
when the color of the medium shifted from yellow to red34 at which point they were extracted. 
Streptomyces strains were cultured in 24-well plates on A1, MS and R5 agar for 7 days before 
extraction. For the extraction, a plug of agar and cell lawn was picked and crushed with a glass 
pipette. First, agar and cells were washed with 500 µL H2O in an ultrasonic bath (30 min) to 
remove salts. Then, agar and cells were extracted subsequently with 500 µL EtOAc, n-BuOH 
and MeOH each (ultrasonic bath, 5 min). Alternatively, Streptomyces samples were extracted by 
vortexing for 30 s with each solvent. After each extraction the solvent was evaporated, the 
residue redissolved in 1 mL MeOH and filtered through a 0.2 µm membrane into HPLC vials. 
Solvent blanks were generated by extracting only media. For the time course experiment, S. 
arenicola CNH-877, CNY-011, CNS-690 and CNS-694 were grown in either liquid A1, ISP2, 
MB, and Production medium (1% soytone, 1% soluble starch, 1 % maltose) supplemented with 
Instant Ocean sea salt. 1 mL of the cultures were extracted after 7, 14, 21 and 28 days with 1 mL 
EtOAc and BuOH and the solvent treated as above.  
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HPLC-MS. Samples were analyzed using an Agilent 6530 Accurate-Mass Q-TOF 
spectrometer coupled to an Agilent 1260 LC system.  A Phenomenex Luna C18 HPLC column 
(2.6 mm, 150 x 4.6 mm) was used under the following LC conditions with 0.1 % TFA: 1–5 min 
(10 % MeCN in H2O), 5–26 min (10–100 % MeCN), 26–28 min (100 % MeCN).  The divert 
valve was set to waste for the first 4 min. Q-TOF MS settings during the LC gradient were as 
follows: positive ion mode mass range 300–1700 m/z, static exclusion 300-400 m/z, MS scan rate 
1/s, MS/MS scan rate 3/s, fixed collision energy 20 keV; source gas temperature 300 °C, gas 
flow 11 L/min, nebulizer 45 psig, scan source parameters: VCap 3000, fragmentor 100, 
skimmer1 65, octopoleRFPeak 750. The MS was auto-tuned using Agilent tuning solution in 
positive mode before each measurement. MS data were analyzed with MassHunter software 
(Agilent). 
Molecular networking and data analysis. All MS/MS data were converted from 
Agilent MassHunter data files (.d) to mzXML file format using the software Trans-Proteomic 
pipeline (Institute for Systems Biology).35 The data were transferred onto the GNPS server 
(gnps.ucsd.edu) and molecular networking was performed using the GNPS data analysis 
workflow using the spectral clustering algorithm.6a Sample attributes were linked to the data 
(146 strains, 2 genera, 3 species, 3 media, 16 locations, 3 solvents). Different parameters (cosine, 
minimum matched peaks) were evaluated to determine the best networking conditions. Finally, a 
cosine of 0.5 and a minimum number of matched peaks of 4 was chosen for further analyses. The 
chosen parameters include mass tolerance for fragment peaks (0.5 Da), parent mass tolerance 
(2.0 Da), a minimum cluster size of 2 and a maximum cluster size of 250. These settings yielded 
the highest number of connected nodes with no standards having clustering with other standards. 
To facilitate network analysis, all nodes that contained ions that were present in the media 
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controls were subtracted from the networks. The spectral networks were imported into Cytoscape 
3.1.036 and visualized using the force-directed layout. Nodes represent parent masses and edge 
thickness corresponds to cosine score. Group and attributes files and Cumulative consensus 
curves were generated according to the GNPS documentations (https://bix-
lab.ucsd.edu/display/Public/GNPS+Documentation+Page). To generate cumulative consensus 
curves, the network was rerun using the same parameters with input files being allocated to the 
spectrum file groups based on attribute. The data is publically accessible as MassIVE datasets 
MSV000078836 and MSV000078839. Ellipsoid area-proportional Venn diagrams were 
generated with the tool eulerAPE v3 (http://www.eulerdiagrams.org/eulerAPE).37 Bioinformatic 
genome, gene cluster and domain analysis was performed using the tools antiSMASH 3.0 
(antismash.secondaymetabolites.org)38 and NaPDoS (napdos.ucsd.edu).39 
Statistical Analysis. The intensity of the precursor ions of MS/MS clusters were 
exported through the “Create Cluster Buckets” option on GNPS (gnps.ucsd.edu) data analysis 
Advanced Output Options. The table was used to perform unsupervised and supervised analysis 
using R statistical environment40 and Qiime bioinformatics pipeline.41 The unsupervised analysis 
consisted of calculating Gower distance with the R package VEGAN42 and using the distance 
matrix to perform Principal Coordinates Analysis (PCoA) using Qiime and visualized using 
EMPeror.43 The supervised analysis consisted of training classifiers for different partitions of the 
data (e.g., classifying samples according to solvent extraction, growth media, or species labels 
based on whole metabolomics profile). The random forest classifier was used through 
randomForest package.29 The model accuracies were calculated subsampling the data in training 
and test datasets with the package caret.44 The random forest sample proximity values were used 
to calculate sample to sample dissimilarities and repeat the PCoA analysis for classification. 
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